Golimumab

Golimumab is a biologic medication used to treat a variety of autoimmune diseases, including rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It is a monoclonal antibody that works by targeting and blocking a protein called tumor necrosis factor-alpha (TNF-alpha), which is involved in the inflammation and damage caused by these conditions. Golimumab is usually given as an injection under the skin, usually every 4 weeks. It may also be used to treat other conditions as determined by your doctor.

Golimumab is a medication used to treat certain autoimmune diseases. Here's a breakdown of its key features:

Function:

  • Golimumab belongs to a class of drugs called tumor necrosis factor-alpha (TNF-alpha) inhibitors.
  • TNF-alpha is a protein involved in the inflammatory response. In autoimmune diseases, the body's immune system mistakenly attacks healthy tissues. Golimumab works by blocking the activity of TNF-alpha, thereby helping to reduce inflammation.

Conditions Treated:

  • Golimumab is primarily used to treat:
    • Rheumatoid arthritis: An autoimmune disease that causes inflammation and pain in the joints.
    • Psoriatic arthritis: A type of arthritis that affects people with psoriasis, a skin condition.
    • Ulcerative colitis: An inflammatory bowel disease (IBD) that causes inflammation and ulcers in the lining of the colon.

Form and Administration:

  • Golimumab is administered as an injection, either under the skin (subcutaneous) or intravenously (into a vein) by a healthcare professional.
  • The frequency of injection depends on the specific condition being treated.

Side Effects:

  • Common side effects include upper respiratory infections, headache, injection site reactions, and fatigue.
  • Serious side effects can occur, though less frequently. These include infections, allergic reactions, and nervous system problems.

Important Considerations:

  • Golimumab weakens the immune system, making you more susceptible to infections.
  • Inform your doctor about any current or past infections before starting Golimumab.
  • It's not suitable for everyone, particularly individuals with certain medical conditions or a history of severe infections.
  • Pregnant or breastfeeding women should consult with their doctor before using Golimumab.

Alternatives:

  • Several other medications are available to treat the conditions for which Golimumab is prescribed. Your doctor will determine the most suitable option based on your individual needs and medical history.

Remember:

  • Consult your doctor for personalized advice on Golimumab or any other medication for managing autoimmune diseases.
  • They can assess your condition, determine the appropriate dosage, and monitor for potential side effects.
  • It's crucial to follow your doctor's instructions for treatment to ensure optimal management of your condition.
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L04 Immunosuppressants
L04A - Immunosuppressants
L04AB Tumor necrosis factor alpha (TNF-α) inhibitors
External Links